Regulation of Vascular Inflammation
Regulation of Vascular Inflammation
批准号:
7228479
负责人:
CHARLES J LOWENSTEIN
金额:
$31.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2008-03-31
关键词:
AnimalsAnti-Inflammatory AgentsAnti-inflammatoryApolipoprotein EApplications GrantsArteriosclerosisAtherosclerosisBiologicalClinical ResearchCoronary ArteriosclerosisCoronary heart diseaseCytoplasmic GranulesCytotoxic T-LymphocytesDataDiseaseEndothelial CellsExocytosisFunctional disorderGrantHeartHumanHydrogen PeroxideInflammationInflammatoryInjuryKnockout MiceMediatingMediator of activation proteinMolecularMusNOS2A geneNOS3 geneNitric OxidePathway interactionsPlatelet aggregationPlayReactive Oxygen SpeciesRegulationRiskRoleSNAP receptorSerum MarkersSystemTransplantationVascular DiseasesWeibel-Palade Bodiesatherogenesishuman NOS2A proteinhuman NOS3 proteininjuredkillingsneurotransmissionnovelvascular inflammation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Atherosclerosis is an inflammatory disease. Clinical studies show that elevated serum markers of inflammation predict an increased risk for atherosclerosis. Animal studies show that inflammatory mediators play a role in atherogenesis. Although pro-inflammatory pathways have been shown to increase atherosclerosis, the protective roles of anti-inflammatory pathways are less well studied. We and others have previously shown that nitric oxide (NO) inhibits vascular diseases. ApoE null mice that also lack the endothelial nitric oxide synthase (eNOS, or NOS3) gene have more severe atherosclerosis than ApoE mice that express NOS3. In humans, endothelial dysfunction (characterized by an inability to produce NO) is associated with coronary artery disease (CAD). Thus, NO may protect the vasculature from atherosclerosis. The molecular mechanisms by which NO inhibits atherosclerosis are unknown. However, we and others recently discovered that NOS decreases inflammation in transplant arteriosclerosis. In particular, we found that the inducible nitric oxide synthase (iNOS, or NOS2) inhibits the release of WeibeI-Palade bodies from endothelial cells in donor hearts. Since WeibeI-Palade bodies contain inflammatory and thrombotic mediators, inhibition of WeibeI-Palade body release may explain part of the anti-inflammatory effects of NO in transplant vasculopathy and other inflammatory vascular diseases, including atherosclerosis. We hypothesize that NO derived from NOS inhibits vascular inflammation, in part by inhibiting WeibeI-Palade body exocytosis. We now propose to explore the molecular mechanisms by which NO inhibits WeibeI-Palade body release. Preliminary Data show that NO blocks WeibeI-Palade body release from cultured endothelial cells. We will begin by determining the mechanisms by which WeibeI-Palade bodies are normally released. We will next define the molecules of the exocytosis machinery that are targets of NO. Finally, we will examine the role of reactive oxygen species in regulating WeibeI-Palade body exocytosis. These studies will characterize novel molecular mechanisms by which radicals regulate vascular inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology
-
批准号:10418628
-
项目类别:
-
资助金额:$62.68万
-
财政年份:2020
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology
-
批准号:10164668
-
项目类别:
-
资助金额:$67.29万
-
财政年份:2020
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Population genomic variation, functional biology, and the risk of venous thrombosis
-
批准号:9750789
-
项目类别:
-
资助金额:$71.08万
-
财政年份:2017
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
VAMP8 regulates endothelial exocytosis and microvascular obstruction
-
批准号:8903561
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2014
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Novel Regulators of Endothelial Exocytosis
-
批准号:8445932
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2013
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Novel Regulators of Endothelial Exocytosis
-
批准号:8604406
-
项目类别:
-
资助金额:$15.04万
-
财政年份:2013
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Exocytosis in the Post-Ischemic Myocardium
-
批准号:7160736
-
项目类别:
-
资助金额:$40.84万
-
财政年份:2006
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Exocytosis and Vascular Inflammation
-
批准号:7115398
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Vascular Inflammation
-
批准号:6889495
-
项目类别:
-
资助金额:$24.53万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Exocytosis and Vascular Inflammation
-
批准号:6847671
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Vascular Inflammation
-
批准号:7426027
-
项目类别:
-
资助金额:$5.2万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Vascular Inflammation
-
批准号:7054712
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Vascular Inflammation
-
批准号:6773530
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Exocytosis and Vascular Inflammation
-
批准号:6951583
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Exocytosis and Vascular Inflammation
-
批准号:7278288
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2004
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulating NOS2 in ischemic & post-ischemic myocardium
-
批准号:6803071
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2003
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulation of Weibel-Palade Body Secretion in AGA
-
批准号:6739499
-
项目类别:
-
资助金额:$34.83万
-
财政年份:2003
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulating NOS2 in ischemic & post-ischemic myocardium
-
批准号:6654181
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2002
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
Regulating NOS2 in ischemic & post-ischemic myocardium
-
批准号:6494012
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2001
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
MEDIATORS OF ACCELERATED GRAFT ARTERIOSCLEROSIS
-
批准号:6448218
-
项目类别:
-
资助金额:$49.81万
-
财政年份:2001
-
负责人:CHARLES J LOWENSTEIN
-
依托单位:
海外基金